Complementary therapy in diabetic patients with chronic complications: A pilot study

Bratislava Medical Journal

Volumn 111, Issue 4, 2010, Pages 205-211

  Palacka, P ^a   Kucharska, J ^a   Murin, J ^a   Dostalova, K ^b   Okkelova, A ^c   Cizova, M ^c   Waczulikova, I ^a   Moricova, S ^b   Gvozdjakova, A ^a  

^a Physics and Informatics   (Slovakia)

^b Angiology Outpatient Department   (Slovakia)

^c Diabetic Outpatient Department   (Slovakia)

Author keywords

Alpha lipoic acid; Alpha tocopherol; Coenzyme Q10; Heart function; Neuropathic diabetic ulcers; Polarised light

Indexed keywords

ANTIOXIDANT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHOTOTHERAPY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL;

ANTIOXIDANTS; COMBINED MODALITY THERAPY; DIABETIC FOOT; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOTOTHERAPY; PILOT PROJECTS;

EID: 77954560215     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Abdella N, Al-Awadi F, Salman A and Armstrong D. Thiobarbituric acid test as a measure of lipid peroxidation in Arab patients with NIDDM. Diabet Res 1990; 15: 173-177.
2. Belardinelli R, Tiano L, Littarru GP.(2008): Oxidative stress, endothelial function and coenzyme Q10. BioFactors 2008; 32 (1-4): 129-133.
3. Bonakdar RA, Guarneri E. Coenzyme Q10. Am Fam Phys 2005; 72: 1065-1070.
4. Chen LH, de Osio Y, Anderson JW. Blood antioxidant defense system and dietary survey of elderly diabetic men. Arch Gerontol Geriatr 1999; 28: 65-83.
5. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. a-tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol: physiological implicati ons. PNAS 1997; 94: 3217-3222.
6. Dominguez C, Gussinye M, Ruiz E, Carrascosa A. Oxidative stress at onset and in early stages of type I diabetes in children and adolescents. Diabet Care 1998; 21: 1736-1742.
7. Dutta A, Dutta SK. Vitamin E and its role in the prevention of atheroscle rosis and carcinogenesis: A review. J Am Coll Nutr 2003; 22: 258-268.
8. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms and therapeutic implications. Endocr Rev 2004; 25: 543-567.
9. Feldman E. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111: 431-433.
10. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GDO, O'Reilly DJ, Packard CJ, Sattar N for the West of Scotland Coronary Prevention Study Group: C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study Diabetes 2002; 51: 1596-1600.
11. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. New Engl J Med 1999; 340: 448-454.
12. Gribauskas PS, Norkus AV, Cherniauskene RC, Varshkiaviche-ne ZZ, Masal'skene W. Malondialdehyde, alpha-tocopherol and reti-nol content of the blood serum in male diabetics. Probl Endokrinol 1986; 32: 46-9.
13. Gvozdjakova A, Kucharska J, Braunova Z, Kolesar P. Beneficial effect of CoQIO on the antioxidative status and metabolism of fats and sugars in diabetic patients. In Abstract book of the First Conference of the International Coenzyme Q10 Association, Boston, 21-24 May, 1998: 95-97.
14. Gvozdjakova A, Kucharska J, Geyer I, Sumbalova Z, Bozek P, Palinkas J. Polarized light stimulates endogenous coenzyme Q, ·-tocopherol plasma level and improves mitochondrial function. Mitochon drion 2005; 5: 226.
15. Gvozdjakova A, Kucharska J, Palinkas J. Polarized light and CoQIO effect in mitochondria (Pre-clinical Study). In: Mitochondrial Medicine, ed. A Gvozdjakova, Netherlands: Springer. 2008: 396-398.
16. Heitzer T, Finckh B, Albers S, Krohn K, Kohlschutter A, Meinertz T. Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress. Free Radic Biol Med 2001; 31: 53-61.
17. Jiang Q, Christen S, Shigenana MK, Ames BN. •-Tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001; 74: 714-722.
18. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992; 33: 385-397.
19. Kucharska J, Braunova Z, Ulicna O, Zlatos L, Gvozdjakova A. Deficit of coenzyme Q10 in heart and liver mitochondria of rats with streptozotocin-induced diabetes. Phys Res 2000; 49: 411-418.
20. Kucharska J, Gvozdjakova A, Snircova M, Mizera S, Schramekova E, Schreinerova Z, Pechan I, Fabian J. The assessment of coenzyme Q10 and alpha-tocopherol in patients with cardiomyopathies of unknown origin: prospective diagnostic possibilities. Bratisl Med J 1996; 97: 351-354.
21. Lang JK, Gohil K, Packer L. Simultaneous determination of tocopherols, ubiquinols, and ubuquinones in blood, plasma, tissue homogenates and subcellular fractions. Anal Biochem 1986; 157: 106-116.
22. Langsjoen PH, Langsjoen PH, Folkers K. Isolated diastolic dys function of the myocardium and its response to CoQIO treatment. Eds. K Folkers, SA Mortensen, GP Littarru, T Yamagami, G Lenaz. Clin Investig 1993; 71: SI40-SI44.
23. Littarru GP, Tiano L. Clinical aspects of coenzyme Q10 in relationship with its bioenergetic and antioxidant properties. Gvozdjakova A (Ed). In Mitochondrial Medicine. Netherlands: Springer, 2008: 303-321.
24. Luft R, Landau BR. Mitochondrial medicine. J Int Med 1995; 238: 405-421.
25. Mitchel P. The vital protonmotive role of coenzyme Q. In: Folkers K, Littarru, Yamagami T (Eds). Biochemical and Clinical Aspects of Coenzyme Q Amsterdam. Elsevier, 1991: 3-10.
26. Miyake Y, Shouzu A, Nishikawa M, Yonemoto T, Shimizu H, Omoto S, Hayakawa T, Inada M. Effect of treatment of 3-hydroxy-3-methylglutaryl coenzyme I reductase inhibitors on serum coenzyme Q10 in diabetic patients. Arzneimittelforschung 1999; 49: 324-329.
27. Oda T. Recovery of the Frank-Starling mechanism by coenzyme Q10 in patients with load-induced contractility depression. Mol Aspect Med 1994; 15 (Suppl): S149-S154.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reactions. Anal Biochem 1979; 95: 351-358.
29. Packard CJ, O'Reilly DS, Caslake MJ, McMahon AD, Ford I, Cooney J, Macphee CH, Suckling KE, Krishna M, Wilkinson FE, Rumley A, Lowe GD. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coro nary Prevention Study Group. New Engl J Med 2000; 343: 1148-1155.
30. Packer L, Witt EH, Tritschler HJ. Alpha-lipoic acid as a biological antioxidant. Free Rad Biol Med 1995; 19: 227-250.
31. Palacka P, Murin J, Gvozdjakova A. Mechanisms of heart damage in diabetic patients (Review). Cardiol 2008; 17: 109-114.
32. Perkins GA, Ellisman MH, Fox DA. The structure-function corre lates of mammalian rod and cone photoreceptor mitochondria: observa tions and unanswered questions. Mitochondrion 2004; 4: 695-703.
33. Polidori MC, Mecocci P, Stahl W, Parente B, Ceccheti R, Cherubini A, Cao P, Sies H, Senin U. Plasma levels of lipophilic antioxidants in very old patients with type 2 diabetes. Diabet Metab Res Rev 2000; 16: 15-19.
34. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. J Amer Med Ass 2001; 286: 327-334.
35. Reunanen A, Knekt P, Aaran RK, Aromaa A. Serum antioxidants and risk of non-insulin-dependent diabetes mellitus. Eur J Clin Nutr 1998; 52: 89-93.
36. Ridker PM, Hennekens CH, Buring JE, Rifai N. Creactive protein and other markers of inflammation in the prediction of cardiovascu lar disease in women. New Engl J Med 2000; 342: 836-843.
37. Salonen JT, Nyssonen K, Tuomainen TP, Pekka HM, Heikki K, Kaplan GA, Lynch J, Helmrich SP, Salonen R. Increased risk of non-insulin-dependent diabetes mellitus at low plasma vitamin E concentrations. A four-year follow up study in men. Brit Med J 1995; 311: 1124-1127.
38. Sies H, Stahl W, Sundquist AR. Antioxidant function of vitamins. Ann NY Acad Sci 1992; 669: 7-20.
39. Takada M, Ikenoya S, Yuzuriha T, Katayama K. Studies on reduced and oxidized coenzyme Q. II. The determination of oxidation-reduction levels of coenzyme Q in mitochondria, microsomes and plasma by high-performance liquid chromatography. Biochem Biophys Acta 1982; 679: 308-314.
40. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1998; 240: 1546-1548.
41. Wagner FW. Classification and treatment program for diabetic, neuropathic and dysvascular foot problems. In Instructional Course Lectures, American Academy of Orthopaedic Surgeons. St. Louis. C.V. Mos-by 1979; 28: 143-165.
42. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schutte K, Kerum G, Malessa R. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabet Care 1999; 22: 1296-1301.
43. Ziegler D, Nowak H, Kempler P, Vargha P, Low PA. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid. A meta-analysis. Diabet Med 2004; 21: 114-121.
44. Zhevago NA, Samoilova KA. Pro- and anti-inflammatory cytokine content in human peripheral blood after its transcutaneous (in vivo) and direct (in vitro) irradiation with polychromatic visible and infrared light. Photomed Laser Surg 2006; 24: 129-139.